 Bala Ramanan
Concepts (215)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endovascular Procedures | 23 | 2025 | 385 | 5.510 |
Why?
| | Aortic Aneurysm, Abdominal | 17 | 2023 | 167 | 4.250 |
Why?
| | Blood Vessel Prosthesis Implantation | 12 | 2023 | 228 | 3.290 |
Why?
| | Peripheral Arterial Disease | 10 | 2025 | 504 | 2.320 |
Why?
| | Vascular Surgical Procedures | 8 | 2024 | 343 | 2.310 |
Why?
| | Carotid Stenosis | 5 | 2024 | 102 | 1.810 |
Why?
| | Radiation Exposure | 4 | 2023 | 63 | 1.770 |
Why?
| | Lower Extremity | 3 | 2025 | 440 | 1.600 |
Why?
| | Ischemia | 4 | 2021 | 422 | 1.530 |
Why?
| | Kidney Failure, Chronic | 3 | 2023 | 597 | 1.380 |
Why?
| | Occupational Exposure | 3 | 2023 | 355 | 1.290 |
Why?
| | Stents | 5 | 2024 | 557 | 1.220 |
Why?
| | Renal Insufficiency, Chronic | 4 | 2023 | 657 | 1.210 |
Why?
| | Limb Salvage | 6 | 2025 | 73 | 1.120 |
Why?
| | Endarterectomy, Carotid | 5 | 2024 | 60 | 1.100 |
Why?
| | Treatment Outcome | 35 | 2025 | 11735 | 1.080 |
Why?
| | Risk Assessment | 17 | 2025 | 3729 | 0.970 |
Why?
| | Risk Factors | 30 | 2025 | 10796 | 0.960 |
Why?
| | Aneurysm | 2 | 2023 | 37 | 0.940 |
Why?
| | Vascular Grafting | 2 | 2025 | 15 | 0.920 |
Why?
| | Radiation Injuries | 2 | 2024 | 149 | 0.890 |
Why?
| | Intermittent Claudication | 1 | 2025 | 122 | 0.820 |
Why?
| | Thoracic Wall | 1 | 2023 | 21 | 0.800 |
Why?
| | Registries | 8 | 2024 | 2392 | 0.790 |
Why?
| | Radiation Protection | 1 | 2023 | 41 | 0.780 |
Why?
| | Radiation Monitoring | 2 | 2022 | 16 | 0.780 |
Why?
| | Time Factors | 20 | 2025 | 7140 | 0.780 |
Why?
| | Splenic Artery | 1 | 2023 | 13 | 0.780 |
Why?
| | Fibromuscular Dysplasia | 1 | 2022 | 8 | 0.760 |
Why?
| | Ischemic Attack, Transient | 1 | 2022 | 71 | 0.710 |
Why?
| | Radiography, Interventional | 5 | 2023 | 128 | 0.670 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2023 | 153 | 0.660 |
Why?
| | Retrospective Studies | 28 | 2025 | 17149 | 0.660 |
Why?
| | Blood Vessel Prosthesis | 5 | 2020 | 140 | 0.650 |
Why?
| | Aged | 35 | 2025 | 25955 | 0.650 |
Why?
| | Radiation Dosage | 4 | 2023 | 193 | 0.620 |
Why?
| | Aortic Valve Stenosis | 1 | 2023 | 255 | 0.620 |
Why?
| | Aged, 80 and over | 15 | 2025 | 8284 | 0.620 |
Why?
| | Databases, Factual | 11 | 2025 | 1494 | 0.600 |
Why?
| | Stroke | 4 | 2024 | 1262 | 0.570 |
Why?
| | Head and Neck Neoplasms | 1 | 2024 | 562 | 0.570 |
Why?
| | Platelet Aggregation Inhibitors | 2 | 2024 | 496 | 0.540 |
Why?
| | Aortic Aneurysm, Thoracic | 2 | 2018 | 138 | 0.540 |
Why?
| | Podiatry | 1 | 2017 | 6 | 0.530 |
Why?
| | Wound Infection | 1 | 2017 | 59 | 0.490 |
Why?
| | Hernia, Inguinal | 2 | 2014 | 43 | 0.490 |
Why?
| | Middle Aged | 29 | 2024 | 35971 | 0.490 |
Why?
| | Watchful Waiting | 2 | 2014 | 90 | 0.480 |
Why?
| | Renal Dialysis | 1 | 2019 | 465 | 0.430 |
Why?
| | Popliteal Artery | 3 | 2024 | 62 | 0.430 |
Why?
| | Wound Healing | 1 | 2017 | 352 | 0.430 |
Why?
| | Humans | 54 | 2025 | 144667 | 0.420 |
Why?
| | Male | 37 | 2025 | 72431 | 0.410 |
Why?
| | Fluoroscopy | 3 | 2023 | 176 | 0.410 |
Why?
| | Bloodless Medical and Surgical Procedures | 1 | 2013 | 5 | 0.400 |
Why?
| | Patient Discharge | 3 | 2021 | 985 | 0.400 |
Why?
| | Female | 38 | 2025 | 78304 | 0.400 |
Why?
| | Postoperative Complications | 10 | 2022 | 2950 | 0.390 |
Why?
| | Blood Loss, Surgical | 1 | 2013 | 110 | 0.380 |
Why?
| | Decision Support Techniques | 2 | 2013 | 461 | 0.350 |
Why?
| | Heart Failure | 1 | 2025 | 2324 | 0.340 |
Why?
| | United States | 19 | 2025 | 16018 | 0.330 |
Why?
| | Education, Medical, Continuing | 1 | 2012 | 133 | 0.330 |
Why?
| | Aortic Aneurysm | 2 | 2021 | 70 | 0.320 |
Why?
| | Chi-Square Distribution | 6 | 2017 | 524 | 0.300 |
Why?
| | Cost-Benefit Analysis | 3 | 2019 | 638 | 0.300 |
Why?
| | Multivariate Analysis | 8 | 2017 | 1537 | 0.290 |
Why?
| | Veterans Health | 2 | 2021 | 189 | 0.290 |
Why?
| | Cardiovascular Diseases | 4 | 2021 | 2172 | 0.280 |
Why?
| | Venous Thromboembolism | 1 | 2013 | 326 | 0.280 |
Why?
| | Frailty | 2 | 2022 | 200 | 0.280 |
Why?
| | Bariatric Surgery | 1 | 2012 | 245 | 0.270 |
Why?
| | Obesity, Morbid | 1 | 2012 | 288 | 0.270 |
Why?
| | Arterial Occlusive Diseases | 2 | 2022 | 90 | 0.270 |
Why?
| | Hospital Mortality | 6 | 2023 | 1033 | 0.250 |
Why?
| | Program Evaluation | 2 | 2024 | 941 | 0.250 |
Why?
| | Quality Improvement | 3 | 2024 | 1287 | 0.250 |
Why?
| | Logistic Models | 8 | 2016 | 2114 | 0.240 |
Why?
| | Veterans | 3 | 2024 | 1614 | 0.230 |
Why?
| | Vascular Patency | 3 | 2023 | 121 | 0.230 |
Why?
| | Clinical Competence | 2 | 2020 | 1237 | 0.220 |
Why?
| | Odds Ratio | 7 | 2021 | 1076 | 0.220 |
Why?
| | Ankle Brachial Index | 1 | 2024 | 41 | 0.210 |
Why?
| | Protective Clothing | 1 | 2023 | 15 | 0.200 |
Why?
| | Angioplasty, Balloon | 1 | 2024 | 93 | 0.200 |
Why?
| | Carotid Artery, Common | 1 | 2023 | 31 | 0.190 |
Why?
| | Prospective Studies | 5 | 2022 | 7994 | 0.190 |
Why?
| | Kaplan-Meier Estimate | 4 | 2021 | 967 | 0.190 |
Why?
| | Arm | 1 | 2023 | 110 | 0.190 |
Why?
| | Renal Artery Obstruction | 1 | 2023 | 29 | 0.190 |
Why?
| | Ureteral Diseases | 1 | 2022 | 4 | 0.190 |
Why?
| | Hospitalization | 1 | 2013 | 2446 | 0.180 |
Why?
| | United States Department of Veterans Affairs | 3 | 2021 | 771 | 0.180 |
Why?
| | Carotid Arteries | 1 | 2023 | 207 | 0.180 |
Why?
| | Surgeons | 3 | 2024 | 341 | 0.180 |
Why?
| | Inpatients | 2 | 2023 | 547 | 0.170 |
Why?
| | Sex Factors | 3 | 2020 | 2104 | 0.170 |
Why?
| | Vascular System Injuries | 1 | 2022 | 78 | 0.170 |
Why?
| | Prosthesis Design | 3 | 2020 | 355 | 0.160 |
Why?
| | Incidence | 4 | 2021 | 2892 | 0.160 |
Why?
| | Leg | 1 | 2022 | 240 | 0.160 |
Why?
| | Abdominal Injuries | 1 | 2022 | 130 | 0.160 |
Why?
| | Eye Protective Devices | 1 | 2020 | 8 | 0.160 |
Why?
| | Aortic Diseases | 1 | 2022 | 125 | 0.160 |
Why?
| | Saphenous Vein | 1 | 2020 | 37 | 0.150 |
Why?
| | Carotid Artery, Internal | 1 | 2020 | 45 | 0.150 |
Why?
| | Proportional Hazards Models | 3 | 2021 | 1322 | 0.150 |
Why?
| | Patient Readmission | 2 | 2017 | 765 | 0.150 |
Why?
| | Lead | 1 | 2020 | 70 | 0.150 |
Why?
| | Blindness | 1 | 2020 | 51 | 0.150 |
Why?
| | Hospital Costs | 2 | 2017 | 125 | 0.150 |
Why?
| | Eye | 1 | 2020 | 110 | 0.150 |
Why?
| | Atherosclerosis | 1 | 2023 | 409 | 0.140 |
Why?
| | Disease-Free Survival | 2 | 2018 | 768 | 0.140 |
Why?
| | Chronic Disease | 2 | 2023 | 1810 | 0.140 |
Why?
| | Wounds, Nonpenetrating | 1 | 2022 | 321 | 0.140 |
Why?
| | Adult | 10 | 2023 | 40489 | 0.140 |
Why?
| | Length of Stay | 4 | 2017 | 1339 | 0.140 |
Why?
| | Occupational Diseases | 1 | 2020 | 165 | 0.140 |
Why?
| | Workload | 1 | 2020 | 167 | 0.140 |
Why?
| | Women's Health | 1 | 2020 | 307 | 0.130 |
Why?
| | Elective Surgical Procedures | 3 | 2013 | 201 | 0.130 |
Why?
| | Inguinal Canal | 2 | 2019 | 11 | 0.130 |
Why?
| | Quality Indicators, Health Care | 1 | 2020 | 335 | 0.130 |
Why?
| | Cost Savings | 1 | 2017 | 85 | 0.130 |
Why?
| | Light | 1 | 2020 | 405 | 0.120 |
Why?
| | Femoral Artery | 3 | 2024 | 190 | 0.120 |
Why?
| | Recovery of Function | 2 | 2020 | 715 | 0.120 |
Why?
| | Tertiary Care Centers | 1 | 2017 | 194 | 0.120 |
Why?
| | San Francisco | 1 | 2016 | 60 | 0.120 |
Why?
| | Critical Illness | 2 | 2020 | 888 | 0.120 |
Why?
| | Alloys | 1 | 2016 | 38 | 0.120 |
Why?
| | Polyesters | 1 | 2016 | 78 | 0.110 |
Why?
| | Prosthesis-Related Infections | 1 | 2016 | 98 | 0.110 |
Why?
| | Severity of Illness Index | 3 | 2020 | 2922 | 0.110 |
Why?
| | Aortic Rupture | 1 | 2014 | 27 | 0.110 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1268 | 0.100 |
Why?
| | Fundoplication | 1 | 2014 | 52 | 0.100 |
Why?
| | Internship and Residency | 1 | 2024 | 1262 | 0.100 |
Why?
| | Treatment Refusal | 1 | 2013 | 98 | 0.100 |
Why?
| | Pseudomyxoma Peritonei | 1 | 2012 | 5 | 0.100 |
Why?
| | Herniorrhaphy | 1 | 2013 | 76 | 0.090 |
Why?
| | Electronic Health Records | 1 | 2021 | 1176 | 0.090 |
Why?
| | Morbidity | 1 | 2013 | 322 | 0.090 |
Why?
| | Renal Artery | 2 | 2023 | 43 | 0.090 |
Why?
| | Abdominal Pain | 1 | 2014 | 147 | 0.090 |
Why?
| | Health Status | 1 | 2017 | 834 | 0.090 |
Why?
| | Peritoneal Neoplasms | 1 | 2012 | 104 | 0.090 |
Why?
| | ras Proteins | 1 | 2012 | 151 | 0.090 |
Why?
| | Patient Care Team | 1 | 2017 | 690 | 0.090 |
Why?
| | Gastroesophageal Reflux | 1 | 2014 | 236 | 0.090 |
Why?
| | Surgical Procedures, Operative | 1 | 2013 | 272 | 0.080 |
Why?
| | Reoperation | 3 | 2018 | 624 | 0.080 |
Why?
| | Young Adult | 3 | 2023 | 14122 | 0.080 |
Why?
| | Pregnancy | 1 | 2023 | 7122 | 0.080 |
Why?
| | Adolescent | 4 | 2023 | 22409 | 0.080 |
Why?
| | Laparoscopy | 1 | 2014 | 477 | 0.070 |
Why?
| | Proto-Oncogene Proteins | 1 | 2012 | 619 | 0.070 |
Why?
| | Hemodynamics | 1 | 2014 | 1113 | 0.070 |
Why?
| | Healthcare Disparities | 1 | 2016 | 736 | 0.070 |
Why?
| | Follow-Up Studies | 3 | 2014 | 5414 | 0.070 |
Why?
| | Survival Analysis | 1 | 2012 | 1370 | 0.070 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2012 | 532 | 0.070 |
Why?
| | Operative Time | 2 | 2020 | 181 | 0.070 |
Why?
| | Models, Statistical | 1 | 2012 | 677 | 0.070 |
Why?
| | Reproducibility of Results | 2 | 2012 | 3414 | 0.060 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2014 | 1742 | 0.060 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 919 | 0.060 |
Why?
| | Myocardial Infarction | 1 | 2012 | 1209 | 0.050 |
Why?
| | Comorbidity | 2 | 2023 | 1652 | 0.050 |
Why?
| | Cohort Studies | 1 | 2013 | 5957 | 0.050 |
Why?
| | Asymptomatic Diseases | 2 | 2013 | 103 | 0.050 |
Why?
| | Career Choice | 1 | 2024 | 233 | 0.040 |
Why?
| | Aorta, Abdominal | 1 | 2022 | 52 | 0.040 |
Why?
| | Mutation | 1 | 2012 | 4081 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2022 | 408 | 0.040 |
Why?
| | Aspirin | 1 | 2024 | 402 | 0.040 |
Why?
| | Fellowships and Scholarships | 1 | 2024 | 355 | 0.040 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 438 | 0.040 |
Why?
| | Vision, Ocular | 1 | 2020 | 47 | 0.040 |
Why?
| | Societies, Medical | 1 | 2024 | 890 | 0.040 |
Why?
| | Guideline Adherence | 1 | 2024 | 586 | 0.040 |
Why?
| | Injury Severity Score | 1 | 2022 | 602 | 0.040 |
Why?
| | Information Dissemination | 1 | 2021 | 222 | 0.040 |
Why?
| | Students, Medical | 1 | 2024 | 374 | 0.040 |
Why?
| | Aorta, Thoracic | 1 | 2022 | 285 | 0.040 |
Why?
| | Glomerular Filtration Rate | 1 | 2023 | 764 | 0.040 |
Why?
| | Education, Medical, Graduate | 1 | 2024 | 562 | 0.040 |
Why?
| | Fibrinolytic Agents | 1 | 2021 | 290 | 0.030 |
Why?
| | Equipment Design | 1 | 2020 | 527 | 0.030 |
Why?
| | Angiography | 1 | 2019 | 208 | 0.030 |
Why?
| | Visual Perception | 1 | 2020 | 182 | 0.030 |
Why?
| | Prognosis | 2 | 2019 | 4312 | 0.030 |
Why?
| | Occupational Health | 1 | 2020 | 210 | 0.030 |
Why?
| | Hospitals, High-Volume | 1 | 2016 | 50 | 0.030 |
Why?
| | Child, Preschool | 2 | 2022 | 11790 | 0.030 |
Why?
| | Health Care Costs | 1 | 2019 | 425 | 0.030 |
Why?
| | Kidney | 1 | 2023 | 1495 | 0.030 |
Why?
| | Smoking | 1 | 2021 | 1467 | 0.030 |
Why?
| | Treatment Failure | 1 | 2014 | 365 | 0.020 |
Why?
| | Age Factors | 1 | 2020 | 3329 | 0.020 |
Why?
| | Perioperative Period | 1 | 2012 | 70 | 0.020 |
Why?
| | Body Mass Index | 1 | 2021 | 2419 | 0.020 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 254 | 0.020 |
Why?
| | Child | 2 | 2022 | 22600 | 0.020 |
Why?
| | Regression Analysis | 1 | 2013 | 998 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2012 | 1705 | 0.020 |
Why?
| | Patient Selection | 1 | 2012 | 727 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2020 | 6399 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2012 | 2117 | 0.020 |
Why?
| | Prevalence | 1 | 2013 | 2839 | 0.010 |
Why?
| | Disease Progression | 1 | 2013 | 2847 | 0.010 |
Why?
| | Infant | 1 | 2020 | 10023 | 0.010 |
Why?
| | Colorectal Neoplasms | 1 | 2012 | 849 | 0.010 |
Why?
| | Phenotype | 1 | 2012 | 3147 | 0.010 |
Why?
|
|
Ramanan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|